animal models and lupus nephritis Archives

Abstract Number: 1837 • ACR/ARHP Annual Meeting 2017
Development of Murine SLE in the Absence of BAFF
William Stohl¹, Ning Yu¹, Samantha Chalmers², Chaim Putterman³ and Chaim O. Jacob¹, ¹Division of Rheumatology, Keck School of Medicine of University of Southern California, Los Angeles, CA, ²Division of Rheumatology, Albert Einstein College of Medicine, Bronx, NY, ³Division of Rheumatology, Albert Einstein College of Medicine, Bronx, NY, USA, Bronx, NY
Background/Purpose: BAFF is a vital survival and differentiation factor for B cells. In human SLE, clinical efficacy with any of 4 different BAFF antagonists is…
Abstract Number: 2561 • ACR/ARHP Annual Meeting 2017
BTK Inhibition Ameliorates Renal Disease in Spontaneous Murine Lupus Nephritis
Samantha Chalmers¹, Elizabeth Glynn², Mark Panzenbeck², Josephine Pelletier², Todd Bosanac², Sara Khalil², Evan Der³, Leal Herlitz⁴, Deborah Webb², Gerald Nabozny⁵, Jay S. Fine², Elliott Klein², Donald Souza⁶, Chaim Putterman⁷ and Meera Ramanujam², ¹Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY, ²Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, ³Albert Einstein College of Medicine, Bronx, NY, ⁴Cleveland Clinic, Cleveland, OH, ⁵[email protected], Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, ⁶Immunology & Inflammation, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, ⁷Division of Rheumatology, Albert Einstein College of Medicine, Bronx, NY, USA, Bronx, NY
Background/Purpose: Bruton's tyrosine kinase (BTK) plays an important role in B cell and FcR mediated myeloid cell activation. We recently described a selective BTK inhibitor,…

Abstracts tagged "animal models and lupus nephritis"

Development of Murine SLE in the Absence of BAFF

BTK Inhibition Ameliorates Renal Disease in Spontaneous Murine Lupus Nephritis